SPECIAL NOTICE
65 -- Notice of Intent to Sole Source – Agilent Technologies
- Notice Date
- 7/8/2016
- Notice Type
- Special Notice
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services - Rockville, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001, United States
- ZIP Code
- 20857-0001
- Solicitation Number
- FDA-NOI-1169185
- Archive Date
- 7/15/2016
- Point of Contact
- Alphonso M. Simmons, Phone: 3017965141
- E-Mail Address
-
alphonso.simmons@fda.hhs.gov
(alphonso.simmons@fda.hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- The Food and Drug Administration intends to award a Sole Source firm-fixed price contract to Agilent Technologies at 5301 Stevens Creek Blvd Santa Clara, CA 95051 in accordance with FAR part 13.106-1(b)(1)(i). This procurement is being conducted under simplified acquisitions procedures in accordance with FAR Parts 12 and 13. The NAICS code is 334516 - Analytical Laboratory Instrument Manufacturing. This procurement is for new Agilent HPLC Components (a) Agilent 1260 Infinity Auto sampler, (b) Agilent 1260 Infinity II Diode Array Detector HS, (c) Open LAB CDS data system with PC, printer, and software, (d) IQ/OQ at installation for FDA's existing Drug Chemistry Section Agilent HPLC. Agilent Technologies is the manufacturer of the Agilent HPLC. This is a one of a kind instrument set-up, only available through Agilent Technologies. The Agilent HPLC is vigorously protected due to trade secret, patent, and other proprietary rights. Agilent Technologies has exclusive rights to the Agilent HPLC, and is US Patented and foreign equivalents, limiting the possibility of other providers supporting this instrument. Without these new components, Agilent HPLC will not be able to conduct regulatory analysis and the Office of Regulatory Affairs mission will suffer as a result. There is no other known source for these components. This notice is not a request for competitive quotes. However, any party that believes it is capable of meeting the requirements as stated herein may submit a written response, i.e. capability statement, which clearly supports and demonstrates its ability to perform the requirements. Any response shall be received by the response date and time of this notice. Any response shall undergo review to determine if it can meet the requirements. A determination by the Government not to compete this proposed contract based upon a response to this notice is solely within the discretion of the Government. Response Date: 4:00 p.m. ET on July 14, 2016. Please email responses to Alphonso Simmons at alphonso.simmons@fda.hhs.gov.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA-NOI-1169185/listing.html)
- Record
- SN04175757-W 20160710/160708234206-4518d7f106fe123ba886539ea32eab4e (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |